Sperm Bank Market Will Witness Growth Based On Rapidly Changing Technology In Assisted Reproductive Procedures Till 2025:Grand View Research,inc.

The global sperm bank market is expected to reach a value of USD 4.96 billion by 2025, according to a new report by Grand View Research, Inc. The technological advancements pertaining to assistive reproduction, increasing number of countries legalizing same-sex marriage, and growing government support toward sperm donation and donor offspring in various countries are some of the crucial factors expected to boost the market over the forecast period.

In 2015, North America held majority of the revenue share of the sperm bank market. The presence of large number of sperm banks and registered laboratories in North America is one of the key factors that can be accounted for the largest share. The regulations for sperm donation vary as per country; most of the countries have limit on the number of donor off springs and prohibition on the sperm usage of a deceased donor.

The increasing prevalence of infertility has led to huge demand for sperms and the presence of favorable government policies pertaining sperm donation and donor offspring are among some of the key factors anticipated to boost the market over the forecast period. Europe is the fastest growing segment owing to the disparity between demand (high) and supply (low) of sperm.

The growing number of insemination procedures, huge demand for known donors, and huge overall cost incurred in analysis and purification for insemination procedures are few of the factors responsible for majority of revenue share of donor insemination segment. However, In Vitro Fertilization (IVF) segment is expected to be the fastest growing segment over the forecast period due to the growing demand for IVF procedures and growing awareness regarding the benefits of IVF over insemination procedures.

Browse full research report on Sperm Bank Market: http://www.grandviewresearch.com/industry-analysis/sperm-bank-market

Further Key Findings from the Study Suggest:

  • In 2015, known donor was the largest donor type segment, owing to the huge cost of known sperms as compared to anonymous
  • Despite the presence of huge number of anonymous donors, this segment held a lower share of the overall the market
  • In 2015, semen analysis held majority of the revenue share due to the growing R&D, academic research, and assisted reproductive procedures.
  • The presence of huge customer base for infertility treatment and withdrawal of one-child policy in China is expected to drive growth in the Asia Pacific region
  • Some of the key players are FairFax Cryobank, Inc.; Cryos International; Androcryos; New England Cryogenic Center; Indian Spermtech; European Sperm Bank; Seattle Sperm Bank; Xytex Sperm Bank, and London Sperm Bank.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the sperm bank market by donor type, service type, end-use and region:

Sperm Bank Market: Donor Type Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Known Donor
  • Anonymous Donor

Sperm Bank Market: Service Type Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Sperm Storage
  • Semen Analysis
  • Genetic Consultation

Sperm Bank Market: End-Use Outlook (Market Revenue in USD Million, 2014 – 2025)

  • Donor Insemination
  • In Vitro Fertilization

Sperm Bank Market Regional Outlook (Market Revenue in USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Denmark
    • Spain
  • Asia Pacific
    • China
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

Healthcare Mobility Solutions Market Is Anticipated To Reach $227.1 Billion By 2025: Grand View Research, Inc.

The global healthcare mobility solutions market is expected to reach USD 227.1 billion by 2025, according to a new study by Grand View Research, Inc. The market is driven by increasing demand for digitalization of healthcare. Rising health-related expenditure is the biggest issue many countries are facing nowadays. Hospitals are struggling to provide quality care and cost-effective services to patients. Moreover, political instability, lack of proactive initiatives, and economic stress are the factors questioning the R&D funding in developing nations.

Despite sufficient funding and insurance programs, there has been a constant increase in health expenditure in the U.S., affecting services offered by providers. To overcome this, healthcare mobility services are the best solutions, which is anticipated to propel the demand for these devices.

U.S. healthcare mobility solutions market, by product & services, 2014 – 2025 (USD Billion)

us-healthcare-mobility-solutions-market.png

Browse full research report on Healthcare Mobility Solutions Market

  • Enterprise mobility platforms are anticipated to show upward shift in the forecast period owing to the growing demand from hospitals and other caregivers, to manage and optimize operational efficiency
  • mHealth application segment is expected to exhibit fastest growth rate over the forecast period. This can be attributed toward the growing adoption of mHealth apps by patients and care providers for remotely accessing patient health information
  • Healthcare mobility solutions found wide applications in workforce management, to improve the operational capabilities of the employees and increase productivity
  • Patient care management practices are anticipated to show lucrative CAGR over the forecast period due to rising patient concerns and demand for continuous monitoring
  • Patients are anticipated to use the healthcare mobility solutions on a large scale in coming years, owing to rising awareness levels and penetration of mHealth apps
  • Asia Pacific is expected to grow at an exponential CAGR as a consequence of high unmet needs and rapidly evolving pharma industry along with the growing awareness levels
  • The key participants are involved in rigorous strategic activities, such as collaborative agreements & acquisitions, to gain competitive advantage in the market
  • For instance, In April 2016, McKesson Acquired Biologics, Inc.a North Carolina-based biologics company that offers oncology pharmacy services to patients & providers and solutions to manufacturers & payers

 For more information: http://www.grandviewresearch.com

 

Healthcare Cyber Security Market Worth USD 10.85 Billion By 2022: Grand View Research, Inc.

Global healthcare cyber security market size is expected to reach nearly USD 10,848.87million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to the growth of the market include the increasing incidences of cyber attacks for misuse of electronic patient health records (E-PHR), social security records, IP theft, and others.

Cyber attacks are constantly increasing across the globe. On previous encounters it was witnessed that cyber attacks were focused on stealing, financial information, billing information, and bank account numbers using stolen devices with un-encrypted data, phishing and spam mails. Technological advancements have led to advanced cyber warfare using SQL injections, advanced persistent threats (APT), zero day attacks, and advanced malware.

Lack of adequate IT spending by healthcare organizations and lack of awareness about cyber crime have exposed the vulnerabilities of healthcare organizations. The overall impact of cyber attacks on the hospitals and healthcare systems is estimated to be nearly six billion per year.

Furthermore, these organizations face internal threats due to factors such as the use of cloud services, unsecure networks, employee negligence, bring your own device (BYOD), lack of internal identification and security systems, stolen devices with un-encrypted files.

Healthcare cyber security market is segmented by, type of threat into malware, ddos, advanced persistent threat (apt), spyware, lost and stolen devices, others. In 2013, Boston Scientific, St.Jude Medical and, Medtronic witnessed cyber attacks and hacking. In 2015, Anthem, which is the second largest health insurance provider in the U.S., witnessed a massive cyber attack leading to loss of 80 million customer records.

Security information and event management (SIEM),risk and compliance management, DDoS mitigation, antivirus, antimalware, identity and access management, intrusion detection system (IDS)/intrusion prevention system (IPS) and others are the solutions included in the scope of the study. These solutions can be used individually or can be used as a suite of products providing layer wise security.

Market dynamics in this sector are dependent on the type of threat, effectiveness, and frequency of attack, ability to detect and destroy. New types of threats are detected each day, hence, the solutions need to be upgraded constantly to provide adequate firewall security and prevent data breach.

Browse full research report on Healthcare Cyber Security Market

Further key findings from the report suggest:

  • In 2014, North America held the largest market share of more than 41% owing to the presence of sophisticated healthcare infrastructure, and increasing collaboration between pharmaceutical, medical device industries, with regulatory authorities. This can be illustrated using the U.S FDA guidance document on networked medical devices.
  • Furthermore, the U.S. is a prime target for cyber crimes due to, the presence of large fortune 500 healthcare organizations, full scale implementation of digital patient records, and use of extensive social security ids for various transactions.
  • Asia Pacific is identified as one of the most lucrative regional market, growing at a CAGR of over 8.5% during the forecast period. Rapidly improving healthcare infrastructure and high level economic growth in developing countries such as China, India, and South Korea is expected to boost usage rates over the forecast period.
  • Increasing number of internet users in China and India is expected to create a huge user base vulnerable to cyber attacks. According to data published by the Internet and Mobile Association of India (IAMAI), the internet user base in India is expected to reach nearly 402 million by December 2015
  • Key players operating in the healthcare cyber security market include, Cisco, IBM, MacAfee, Paulo Alto Networks, Symantec, Trend Micro Lockheed Martin, FireEye, Northrop Grumma, Kaspersky etc.

 For more information: http://www.grandviewresearch.com

 

Healthcare Analytics Market Is Predicted To Grow Swiftly Due To Efforts To Reduce The Spiraling Healthcare Costs Till 2024: Grand View Research, Inc.

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

Predictive Analytics market estimates and trends

 

 

healthcare-analytics-market.png

Browse full research report on Healthcare Analytics Market

Further key findings from the report suggest:

  • Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.
  • The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.
  • The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.
  • On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.
  • The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.
  • The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.
  • The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.
  • North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.
  • The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.
  • Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.
  • For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

 For more information: http://www.grandviewresearch.com

eClinical Solutions Market Is Expected To Reach USD 10.5 Billion By 2024: By Grand View Research, Inc.

eClinical solutions market is expected to reach USD 10.5 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base.

Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future.

The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF).

The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).

Global eClinical solutions market, 2013 – 2024 (USD Million)

eclinical-solutions-market.png

Browse full research report on eClinical Solutions Market

Further key findings from the report suggest:

  • In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
  • The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s self-reports by pharmaceutical companies.
  • The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others.

 For more information: http://www.grandviewresearch.com

Digital Therapeutics Market Size Will Grow At A CAGR Of 21.0% CAGR from 2014 to 2020: Grand View Research, Inc.

The global digital therapeutics market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth.

Digital therapeutics, commonly known as software-for drugs has been gaining much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important benefits offered by digital therapeutics.

With an increase in the internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. This serves in a discrete and non-interventional manner to persuade individuals to adopt healthier lifestyles and improve physical well-being. Captivating design, extended assessment, and digital tracking are features that are attributing to increasing adoption of digital therapeutics by patients, employers, providers and others.

The North American region contributed to the largest market share owing to technologically advanced medical infrastructure and successful execution of ambulatory health in their healthcare system. Emerging countries like India, China and Brazil are also expected to flourish during the forecast period owing to adoption of enhanced healthcare infrastructure and medical technologies to curb the prevention of chronic diseases.

U.S. digital therapeutics market, by application, 2014 – 2025 (USD million)

us-digital-therapeutics-market

Browse full research report on Digital Therapeutics Market:

Further key findings from the report suggest:

  • The global digital therapeutics market size was estimated at $1.7 Billion in 2016 and is expected to grow at 21.0% CAGR from 2017 to 2025
  • Diabetes is expected to gain the largest market share on the basis of application owing to increasing incidence rates globally and preventive steps taken to reduce them
  • Obesity is also expected to account for a considerable market share due to various healthcare reforms to curb the disease initially and prevent further costs associated with the disease
  • The adoption of digital therapeutics offers reduction in healthcare costs associated with diseases like diabetes and obesity and are thus being used on an increasing scale
  • Digital tracking, continuous monitoring, and management of physical activity and eating habits are factors that are propelling the growth of the market
  • Increasing usage in preventive areas for a wide range of diseases and disorders like respiratory disorders, CVD, and CNS disease are attributes that are bringing about growth of the market
  • Patients accounted for the largest market share in the end-user’s segment owing to user-friendly interface and effective management of diseases
  • The North American region accounted for the highest revenue owing to technological advancement and healthcare expenditure to curb rise in number of chronic diseases
  • The Asia Pacific region is expected to garner considerable growth during the forecast period owing to increasing adoption of advanced healthcare technologies and rise in number of chronic diseases

 For more information: http://www.grandviewresearch.com

 

Pharmacovigilance Market Size Will Grow At 13.1% CAGR from 2014 to 2025: Grand View Research, Inc.

The global pharmacovigilance (PV) market is expected to reach USD 10.27 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 13.1% CAGR owing to Increasing incidence of ADR is key driver for the growth of pharmacovigilance market. As of 2015, the U.S. FDA received approximately 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions (ADRs). This shows the potential demand for implementing safety and pharmacovigilance services over the forecast period

According to World Health Organization’s (WHO) report on pharmaceuticals consumption, medicines to treat chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital set ups. Owing to this, there has been a significant rise in the number of medicines made available to healthcare consumers. Rising demand for drugs has significantly heightened the need for novel therapeutics development via extensive clinical trials, which is further expected to serve this market with lucrative opportunities.

Major pharmaceutical companies are involved in extensive R&D initiatives for development of innovative therapeutic molecules. This has resulted in increased rate of drug development. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for PV services during the forecast period.

Moreover, leading pharma companies in developed countries are focusing toward the outsourcing PV service in an attempt to reduce cost and minimize operational expenses. This is anticipated to serve as opportunity for contact research organizations in developing regions to gain more revenue share.

The companies are undertaking strategic initiatives such as collaboration with the PV service providers to get access to medical information and manage PV workflows. For instance, In April 2017, Accenture entered in a collaborative agreement with BioCelebrate to develop a platform for aggregating and analyzing clinical information for improvement in drug developing efficiency, thus enhancing its R&D capabilities. These factors are anticipated to fuel the market growth.

U.S. pharmacovigilance market revenue by clinical trial phase, 2014 – 2025 (USD million)

us-pharmacovigilance-market

Browse full research report on Pharmacovigilance Market

Further key findings from the report suggest:

  • The hardware segment is estimated to grow at a CAGR of over 90% over the forecast period. Companies such as Sony and Microsoft are expected to commercialize their devices in 2016, which is expected to bolster growth over the forecast period. Further, several companies are working on enhancing the quality of sensors and processors used in AR devices. For instance, Google has collaborated with the chip manufacturers to build camera components and processors for Android phones.
  • Increasing penetration of smartphones and tablets are expected to drive the software segment, growing at a CAGR of over 55% from 2016 to 2024. Increasing demand for AR apps in retail, gaming and entertainment is expected to contribute to the industry growth.
  • The head-mounted display (HMD) segment is anticipated to dominate the market growing at a CAGR of nearly 70%from 2016 to 2024. It can be attributed to the increasing scope of applications across the military, medicine, scientific visualization, manufacturing, education, training, navigation, and entertainment. The other factors driving demand include better content connectivity, enhanced user-experience and improved Field of View (FOV).
  • The adoption of smart glasses is expected to increase significantly in the consumer segment. Several companies are developing advanced smart glasses which are more user-friendly, light weight and offer better FOV.
  • Automotive sectors expected to grow at CAGR of over 70% over the forecast period. Virtual technologies are increasingly used in automotive in response to the rising number of model and equipment variants in the vehicle design and development process. For instance, Volkswagen used spatial AR to put across virtual data onto the actual vehicle design models that allow the analyses of components. As a result, it saves time and cost required for product development.
  • Asia Pacific AR market is estimated to reach over USD 44.30 billion by 2024. China is anticipated to drive regional growth with the increase in adoption of AR devices and mobile apps. In 2014, China witnessed a rapid enhancement in hardware manufacturing, as a result, several chipset manufacturers are planning to support AR technology by immensely investing in the technology.
  • The key industry participants include AU Optronics Corp., Cambridge Display Technology Ltd., LG Display Co., Mitsubishi Electric Corporation, Panasonic Corporation, Sony Corp., and Toshiba Corp. The players engage in frequent merger & acquisitions to increase their product portfolio and geographical presence to gain competitive advantage.

 For more information: http://www.grandviewresearch.com